[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 10359 Introduced in House (IH)]

<DOC>






119th CONGRESS
  2d Session
                               H. R. 10359

To amend the Federal Food, Drug, and Cosmetic Act to permanently extend 
 the authority of the Secretary of Health and Human Services to award 
     priority review vouchers for rare pediatric disease products.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           September 14, 2026

      Mr. Bilirakis (for himself, Ms. Barragan, Mrs. Cammack, Mr. 
 Auchincloss, Mr. Kean, and Mr. Mullin) introduced the following bill; 
       which was referred to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
To amend the Federal Food, Drug, and Cosmetic Act to permanently extend 
 the authority of the Secretary of Health and Human Services to award 
     priority review vouchers for rare pediatric disease products.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Priority for Pediatric Cures Act''.

SEC. 2. PERMANENT EXTENSION OF AUTHORITY TO AWARD PRIORITY REVIEW 
              VOUCHERS FOR RARE PEDIATRIC DISEASE PRODUCTS.

    Section 529(b) of the Federal Food, Drug, and Cosmetic Act (21 
U.S.C. 360ff(b)) is amended by striking paragraph (5).
                                 <all>